 Secondary prevention acute myocardial infarction beta-blocking agents calcium antagonists discovery beta blockers useful hypotensive antianginal antiarrhythmic properties interest clinicians researchers pharmaceutical community addition minor differences variety ancillary properties speculation specific classes drugs advantages classes enthusiasm reports first small trials beta blockers postmyocardial infarction mortality rate commercial support necessary different beta blockers clinical setting plethora beta blockers available study considerable improvement design implementation large clinical trials apparent discrepancies results various trials meta-analysis indicates beta blockers postinfarction mortality meta-analysis particular drug specific dose use individual patient clinical practice results individual trials conclusions meta-analysis clinical utility beta blockers secondary prevention myocardial infarction experimental evidence calcium antagonists infarct size series large studies calcium antagonists effect mortality patients myocardial infarction Lessons beta-blocker trials rapid evaluation efficacy calcium antagonists setting clear beta blockers calcium antagonists effective secondary prevention myocardial infarction